BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1093644)

  • 1. Comparison of the immunosuppressive action of antilymphocytic sera directed against normal and sensitized lymphocytes.
    Kubik-Maślanka K
    Bull Acad Pol Sci Biol; 1975; 23(1):7-13. PubMed ID: 1093644
    [No Abstract]   [Full Text] [Related]  

  • 2. [Response of the lymphoid system to skin allotransplantation following administration of ALS against normal and passively sensitized lymphocytes].
    Fedorich VN
    Fiziol Zh; 1977; 23(6):837-9. PubMed ID: 338372
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunodepressive properties of antilymphocytic sera].
    Govallo VI; Kosmiadi GA
    Biull Eksp Biol Med; 1968 Oct; 66(10):77-80. PubMed ID: 4917690
    [No Abstract]   [Full Text] [Related]  

  • 4. Modification of the ocular immune response. I. Use of antilymphocytic serum to prevent immune rejection of penetrating corneal homografts.
    Waltman SR; Faulkner HW; Burde RM
    Invest Ophthalmol; 1969 Apr; 8(2):196-200. PubMed ID: 4887870
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of tolerance with antilymphocytic serum.
    Lance EM; Medawar PB
    Transplant Proc; 1969 Mar; 1(1):429-32. PubMed ID: 4944254
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the immunodepressive action of antilymphocytic serum in transplantation].
    Petrovskiĭ BV; Volkov MV; Govallo VI; Krylov VS; Kosmiadi GA; Grigor'eva MP; Kopelian II; Mikhaĭlov IF; Freĭman VB
    Khirurgiia (Mosk); 1969 Oct; 45(10):33-6. PubMed ID: 4906855
    [No Abstract]   [Full Text] [Related]  

  • 7. [Homologous liver transplantation in the dog under immunsuppressive treatment with antilymphocytic serum].
    Pichlmayr R; Mikaéloff P; Messmer K; Rassat JP; Bomel J; Tidow G; Fateh-Moghadam A; Junghans M; Brendel W
    Z Gesamte Exp Med Einschl Exp Chir; 1968; 146(3):261-74. PubMed ID: 4972213
    [No Abstract]   [Full Text] [Related]  

  • 8. [The feasibility of prolonging the visability of allotransplants by using antilymphocytic and antithrombocytic sera].
    Khundanov LI; Verbitskiĭ MSh; Artsimovich NG; Kipervasser EM; Lagutina NIa
    Probl Gematol Pereliv Krovi; 1972 Feb; 17(2):42-50. PubMed ID: 4558981
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of different lymphoid target cells in determining the correlation of in vitro and in vivo activities of antilymphocyte sera.
    Végh P; Balough E; Jánossy T; Erdös E
    Z Immunitatsforsch Exp Klin Immunol; 1974 Jun; 147(2):162-74. PubMed ID: 4283007
    [No Abstract]   [Full Text] [Related]  

  • 10. Antilymphocyte serum: summary and further observations.
    Woodruff MF
    Transplantation; 1967 Jul; 5(4):Suppl:1127-33. PubMed ID: 4860606
    [No Abstract]   [Full Text] [Related]  

  • 11. An in vitro test of the immunosuppressive activity of antilymphocyte serum.
    Möller G; Lundgren G; Balner H
    Transplantation; 1970 Feb; 9(2):166-8. PubMed ID: 4984355
    [No Abstract]   [Full Text] [Related]  

  • 12. Antilymphocyte serum or antithymus serum.
    Nagaya H
    Arch Intern Med; 1970 Mar; 125(3):499-502. PubMed ID: 4906901
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocytes and antilymphocytic serum.
    Woodruff M
    Endeavour; 1969 May; 28(104):65-7. PubMed ID: 4183771
    [No Abstract]   [Full Text] [Related]  

  • 14. [A comparative study of the effect of ALS against normal and sensitized lymphocytes on the viability of rat skin transplants].
    Antonenko LI
    Fiziol Zh; 1974; 20(5):590-6. PubMed ID: 4619073
    [No Abstract]   [Full Text] [Related]  

  • 15. The ocular immune response. II. Immune rejection of penetrating corneal homografts. Early versus late treatment with antilymphocyte serum.
    Waltman SR; Burde RM; Faulkner HW
    Transplantation; 1969 Aug; 8(2):147-51. PubMed ID: 4896328
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
    Monaco AP; Franco DJ
    Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of allograft immunity in mice. II. Mechanism of target cell inactivation in vitro by sensitized lymphocytes.
    Mauel J; Rudolf H; Chapuis B; Brunner KT
    Immunology; 1970 Apr; 18(4):517-35. PubMed ID: 5421033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biologic fundamentals and advances in kidney transplantation. IV. Immunosuppression with antilymphocytic serum and specific tolerances].
    Lawson RK; Kirchheim D
    Urologe; 1967; 6(6):359-67. PubMed ID: 4873352
    [No Abstract]   [Full Text] [Related]  

  • 19. Mode of action of antilymphocyte sra (ALS).
    Harris NS; Merino GE; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):797-9. PubMed ID: 4398511
    [No Abstract]   [Full Text] [Related]  

  • 20. Antilymphocyte serum and the induction of tolerance to transplantation antigens.
    Lance EM; Medawar PB
    Fed Proc; 1970; 29(1):151-2. PubMed ID: 4391648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.